Valuation: Universal Vision Biotechnology Co., Ltd.

Market Cap 11.61B 359M 315M 293M 269M 505M 34.55B 513M 3.48B 1.36B 16.99B 1.35B 1.32B 58.73B P/E 2026 *
10.2x
P/E 2027 * -
Enterprise Value 11.61B 359M 315M 293M 269M 505M 34.55B 513M 3.48B 1.36B 16.99B 1.35B 1.32B 58.73B EV / Sales 2026 *
2.73x
EV / Sales 2027 * 2.61x
Free-Float
47.64%
Yield 2026 *
5.87%
Yield 2027 * -
05-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-04 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
11-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
24-11-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-09 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024 CI
1 day+0.37%
1 week+2.24%
1 month+2.62%
3 months+9.16%
6 months-10.16%
Current year-6.16%
1 week 132.5
Extreme 132.5
141
1 month 130.5
Extreme 130.5
148
Current year 122
Extreme 122
154
1 year 122
Extreme 122
214.5
3 years 122
Extreme 122
381.13
5 years 122
Extreme 122
432.08
10 years 18.64
Extreme 18.6433
432.08
Manager TitleAgeSince
Chief Executive Officer - 2010-01-31
Director of Finance/CFO - 2016-03-31
President - -
Director TitleAgeSince
Chairman - 2012-06-27
Director/Board Member - 2003-06-01
Director/Board Member 66 2012-06-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+2.24%-35.83%-63.51% 359M
+0.99%-1.92%-33.86%-7.10% 85.56B
+1.90%-1.69%-24.08%-23.46% 33.28B
+0.11%-1.95%-4.73%-27.32% 13.71B
-0.27%+3.48% - - 10.04B
-0.34%-3.62%-30.00%+474.85% 1.81B
-4.61%-4.09%-41.43%-67.19% 1.4B
-3.40%-6.73%-40.68%-31.66% 801M
-1.34%-1.04%+4.25%-8.68% 787M
+1.39%-0.65%+42.31%-32.42% 759M
Average -0.52%-2.02%-18.23%+23.72% 14.85B
Weighted average by Cap. +0.92%-1.75%-28.06%-7.77%

Financials

2026 *2027 *
Net sales 4.25B 131M 115M 107M 98.51M 185M 12.66B 188M 1.27B 498M 6.22B 493M 483M 21.51B 4.44B 137M 121M 112M 103M 193M 13.22B 196M 1.33B 520M 6.5B 515M 504M 22.47B
Net income 1.14B 35.3M 31.01M 28.83M 26.46M 49.71M 3.4B 50.48M 342M 134M 1.67B 133M 130M 5.78B -
Net Debt - -
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
26-07-24 NT$137.00 +0.37% 231,905
26-07-23 NT$136.50 -1.44% 157,014
26-07-22 NT$138.50 -0.36% 257,731
26-07-21 NT$139.00 +2.58% 276,758
26-07-20 NT$135.50 +1.12% 232,154
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
137.00TWD
Average target price
150.00TWD
Spread / Average Target
+9.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3218 Stock